Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nasal polyps
Pharma
AstraZeneca's Fasenra hit with FDA rejection
The FDA is asking for additional clinical trial data, and AstraZeneca is already running a separate phase 3 trial.
Angus Liu
Mar 14, 2022 10:20am
GSK's Nucala scored a class-first IL-5 win in nasal polyps
Jul 29, 2021 4:42pm
GlaxoSmithKline's Nucala snags FDA nod for blood cell syndrome
Sep 28, 2020 10:00am
AZ's Fasenra chases GSK, Sanofi-Regeneron in nasal polyps
Sep 10, 2020 10:59am
GSK's Nucala scores Dupixent-hunting trial win in nasal polyps
Apr 6, 2020 9:50am
OptiNose's Xhance could zoom past predictions to blockbuster land
Apr 11, 2018 10:25am
